Replies to post #383 on Bluebird Bio Inc (BLUE)

[Moose412]

You should post more. I have faith in Gina Wang's rating, and I also believe whether or not the first patient receiving Lyfgenia needs to have a second cell collection is going to be influential in significant ways.